Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model

Cell Transplantation

Volumn 22, Issue 5, 2013, Pages 855-870

  Choi, Chan Il ^a   Lee, Young Don ^a   Kim, Heejaung ^b   Kim, Seung Hyun ^b   Suh Kim, Haeyoung ^a   Kim, Sung Soo ^a  

^a Ajou University School of Medicine   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Amyotrophic lateral sclerosis (ALS); Cu2+ Zn2+ superoxide dismutase; Mesenchymal stem cells (MSCS); Neurogenin 1 (ngn1); Superoxide dismutase 1 (SOD1)

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROGENIN 1;

ADOLESCENT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; MOUSE; NERVE CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SPINAL CORD; TROPISM; UPREGULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW CELLS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; NERVE TISSUE PROTEINS; RECEPTORS, CCR2; SPINAL CORD; SUPEROXIDE DISMUTASE; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 84875917163     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X637019     Document Type: Article

References (74)

1. Alexander, G. M.; Erwin, K. L.; Byers, N.; Deitch, J. S.; Augelli, B. J.; Blankenhorn, E. P.; Heiman-Patterson, T. D. Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS. Brain Res. Mol. Brain Res. 130:7-15; 2004.
2. Alexianu, M. E.; Kozovska, M.; Appel, S. H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57:1282-1289; 2001.
3. Appel, S. H.; Smith, R. G.; Alexianu, M. F.; Engelhardt, J. I.; Stefani, E. Autoimmunity as a n etiological factor in sporadic amyotrophic lateral sclerosis. Adv. Neurol. 68:47-57; 1995.
4. Bakshi, A.; Barshinger, A. L.; Swanger, S. A.; Madhavani, V.; Shumsky, J. S.; Neuhuber, B.; Fischer, I. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion: A novel method for minimally invasive cell transplantation. J. Neurotrauma 23:55-65; 2006.
5. Bang, O. Y.; Lee, J. S.; Lee, P. H.; Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57:874-882; 2005.
6. Barneoud, P.; Lolivier, J.; Sanger, D. J.; Scatton, B.; Moser, P. Quantitative motor assessment in FALS mice: A longitudinal study. Neuroreport 8:2861-2865; 1997.
7. Berger, M. M.; Kopp, N.; Vital, C.; Redl, B.; Aymard, M.; Lina, B. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 54:20-25; 2000.
8. Bradley, W. G. Overview of motor neuron disease: Classification and nomenclature. Clin. Neurosci. 3:323-326; 1995.
9. Brown, Jr., R. H.; Robberecht, W. Amyotrophic lateral sclerosis: Pathogenesis. Semin. Neurol. 21:131-139; 2001.
10. Chen, L. C.; Smith, A.; Ben, Y.; Zukic, B.; Ignacio, S.; Moore, D.; Lee, N. Temporal gene expression patterns in G93A/SOD1 mouse. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 5:164-171; 2004.
11. Cho, K. J.; Chung, Y. H.; Shin, C.; Shin, D. H.; Kim, Y. S.; Gurney, M. E.; Lee, K. W.; Cha, C. I. Reactive astrocytes express p53 in the spinal cord of transgenic mice expressing a human Cu/Zn SOD mutation. Neuroreport 10:3939-3943; 1999.
12. Choi, C. I.; Lee, Y. D.; Gwag, B. J.; Cho, S. I.; Kim, S. S.; Suh-Kim, H. Effects of estrogen on life span and motor functions in female hSOD1 G93A transgenic mice. J. Neurol. Sci. 268:40-47; 2008.
13. Corti, S.; Locatelli, F.; Papadimitriou, D.; Del Bo, R.; Nizzardo, M.; Nardini, M.; Donadoni, C.; Salani, S.; Fortunato, F.; Strazzer, S.; Bresolin, N.; Comi, G. P. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 130:1289-1305; 2007.
14. Deng, W.; Obrocka, M.; Fischer, I.; Prockop, D. J. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem. Biophys. Res. Comm. 282:148-152; 2001.
15. Deng, Y. B.; Liu, X. G.; Liu, Z. G.; Liu, X. L.; Liu, Y.; Zhou, G. Q. Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: Evidence from a study in rhesus monkeys. Cytotherapy 8:210-214; 2006.
16. Elliott, J. L. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 95:172-178; 2001.
17. Ferrero, I.; Mazzini, L.; Rustichelli, D.; Gunetti, M.; Mareschi, K.; Testa, L.; Nasuelli, N.; Oggioni, G. D.; Fagioli, F. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Cell Transplant. 17:255-266; 2008.
18. Garbuzova-Davis, S.; Sanberg, C. D.; Kuzmin-Nichols, N.; Willing, A. E.; Gemma, C.; Bickford, P. C.; Miller, C.; Rossi, R.; Sanberg, P. R. Human umbilical cord blood treatment in a mouse model of ALS: Optimization of cell dose. PLoS One 3:e2494; 2008.
19. Garbuzova-Davis, S.; Willing, A. E.; Milliken, M.; Saporta, S.; Sowerby, B.; Cahill, D. W.; Sanberg, P. R. Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2:175-180; 2001.
20. Garbuzova-Davis, S.; Willing, A. E.; Milliken, M.; Saporta, S.; Zigova, T.; Cahill, D. W.; Sanberg, P. R. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Exp. Neurol. 174:169-180; 2002.
21. Garbuzova-Davis, S.; Willing, A. E.; Saporta, S.; Justen, E. B.; Misiuta, I. E.; Dellis, J.; Sanberg, P. R. Multiple transplants of hNT cells into the spinal cord of SOD1 mouse model of familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 7:221-226; 2006.
22. Gurney, M. E. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J. Neurol. Sci. 152 Suppl 1:S67-S73; 1997.
23. Gurney, M. E.; Pu, H.; Chiu, A. Y.; Dal Canto, M. C.; Polchow, C. Y.; Alexander, D. D.; Caliendo, J.; Hentati, A.; Kwon, Y. W.; Deng, H. X.; Chen, W.; Zhai, P.; Sufit, R. L.; Siddique, T. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-1775; 1994.
24. Habisch, H. J.; Janowski, M.; Binder, D.; Kuzma- Kozakiewicz, M.; Widmann, A.; Habich, A.; Schwalenstocker, B.; Hermann, A.; Brenner, R.; Lukomska, B.; Domanska-Janik, K.; Ludolph, A. C.; Storch, A. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: Limited intraparenchymal migration and survival narrows therapeutic effects. J. Neural. Transm. 114:1395-1406; 2007.
25. Hall, E. D.; Oostveen, J. A.; Gurney, M. E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23:249-256; 1998.
26. Hofstetter, C. P.; Schwarz, E. J.; Hess, D.; Widenfalk, J.; El Manira, A.; Prockop, D. J.; Olson, L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. USA 99:2199-2204; 2002.
27. Hou, L. L.; Zheng, M.; Wang, D. M.; Yuan, H. F.; Li, H. M.; Chen, L.; Bai, C. X.; Zhang, Y.; Pei, X. T. [Migration and differentiation of human bone marrow mesenchymal stem cells in the rat brain]. Sheng Li Xue Bao 55:153-159; 2003.
28. Ji, J. F.; He, B. P.; Dheen, S. T.; Tay, S. S. Expression of chemokine receptors CXCR4, CCR2, CCR5 and CX3CR1 in neural progenitor cells isolated from the subventricular zone of the adult rat brain. Neurosci. Lett. 355:236-240; 2004.
29. Kim, S. S.; Choi, J. M.; Kim, J. W.; Ham, D. S.; Ghil, S. H.; Kim, M. K.; Kim-Kwon, Y.; Hong, S. Y.; Ahn, S. C.; Kim, S. U.; Lee, Y. D.; Suh-Kim, H. cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK. Neuroreport 16:1357-1361; 2005.
30. Kim, S. S.; Yoo, S. W.; Park, T. S.; Ahn, S. C.; Jeong, H. S.; Kim, J. W.; Chang, D. Y.; Cho, K. G.; Kim, S. U.; Huh, Y.; Lee, J. E.; Lee, S. Y.; Lee, Y. D.; Suh-Kim, H. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells 26:2217-2228; 2008.
31. Ko, I. K.; Kim, B. S. Mesenchymal stem cells for treatment of myocardial infarction. Int. J. Stem Cells 1:49-54; 2008.
32. Kurozumi, K.; Nakamura, K.; Tamiya, T.; Kawano, Y.; Ishii, K.; Kobune, M.; Hirai, S.; Uchida, H.; Sasaki, K.; Ito, Y.; Kato, K.; Honmou, O.; Houkin, K.; Date, I.; Hamada, H. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol. Ther. 11:96-104; 2005.
33. Li, Y.; Chen, J.; Wang, L.; Zhang, L.; Lu, M.; Chopp, M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci. Lett. 316:67-70; 2001.
34. Lu, D.; Mahmood, A.; Wang, L.; Li, Y.; Lu, M.; Chopp, M. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 12:559-563; 2001.
35. Lu, P.; Blesch, A.; Tuszynski, M. H. Induction of bone marrow stromal cells to neurons: Differentiation, transdifferentiation, or artifact? J. Neurosci. Res. 77:174-191; 2004.
36. Mahmood, A.; Lu, D.; Chopp, M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J. Neurotrauma 21:33-39; 2004.
37. Mahmood, A.; Lu, D.; Lu, M.; Chopp, M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53:697-702; 2003.
38. Martin, L. J.; Liu, Z. Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice. J. Neuropathol. Exp. Neurol. 66:1002-1018; 2007.
39. Mazo, M.; Gavira, J. J.; Abizanda, G.; Moreno, C.; Ecay, M.; Soriano, M.; Aranda, P.; Collantes, M.; Alegria, E.; Merino, J.; Penuelas, I.; Garcia Verdugo, J. M.; Pelacho, B.; Prosper, F. Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat. Cell Transplant. 19:313-328.
40. Mazzini, L.; Mareschi, K.; Ferrero, I.; Vassallo, E.; Oliveri, G.; Nasuelli, N.; Oggioni, G. D.; Testa, L.; Fagioli, F. Stem cell treatment in Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 265:78-83; 2008.
41. McGeer, P. L.; McGeer, E. G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459-470; 2002.
42. Menzies, F. M.; Ince, P. G.; Shaw, P. J. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem. Int. 40:543-551; 2002.
43. Miana-Mena, F. J.; Munoz, M. J.; Yague, G.; Mendez, M.; Moreno, M.; Ciriza, J.; Zaragoza, P.; Osta, R. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 6:55-62; 2005.
44. Migheli, A.; Cordera, S.; Bendotti, C.; Atzori, C.; Piva, R.; Schiffer, D. S-100b protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 261:25-28; 1999.
45. Mitrecic, D.; Nicaise, C.; Gajovic, S.; Pochet, R. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transplant. 19:537-548; 2010.
46. Munoz-Elias, G.; Woodbury, D.; Black, I. B. Marrow stromal cells, mitosis, and neuronal differentiation: Stem cell and precursor functions. Stem Cells 21:437-448; 2003.
47. Nagai, A.; Kim, W. K.; Lee, H. J.; Jeong, H. S.; Kim, K. S.; Hong, S. H.; Park, I. H.; Kim, S. U. Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS One 2:e1272; 2007.
48. Nakamizo, A.; Marini, F.; Amano, T.; Khan, A.; Studeny, M.; Gumin, J.; Chen, J.; Hentschel, S.; Vecil, G.; Dembinski, J.; Andreef, M.; Lang, F. F. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 65:3307-3318; 2005.
49. Natsu, K.; Ochi, M.; Mochizuki, Y.; Hachisuka, H.; Yanada, S.; Yasunaga, Y. Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers. Tissue Eng. 10:1093-1112; 2004.
50. Neuhuber, B.; Gallo, G.; Howard, L.; Kostura, L.; Mackay, A.; Fischer, I. Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: Disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J. Neurosci. Res. 77:192-204; 2004.
51. Ohta, M.; Suzuki, Y.; Noda, T.; Ejiri, Y.; Dezawa, M.; Kataoka, K.; Chou, H.; Ishikawa, N.; Matsumoto, N.; Iwashita, Y.; Mizuta, E.; Kuno, S.; Ide, C. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol. 187:266-278; 2004.
52. Park, K. I.; Hack, M. A.; Ourednik, J.; Yandava, B.; Flax, J. D.; Stieg, P. E.; Gullans, S.; Jensen, F. E.; Sidman, R. L.; Ourednik, V.; Snyder, E. Y. Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: Evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells. Exp. Neurol. 199:156-178; 2006.
53. Przedborski, S.; Mitsumoto, H.; Rowland, L. P. Recent advances in amyotrophic lateral sclerosis research. Curr. Neurol. Neurosci. Rep. 3:70-77; 2003.
54. Rosen, D. R.; Siddique, T.; Patterson, D.; Figlewicz, D. A.; Sapp, P.; Hentati, A.; Donaldson, D.; Goto, J.; O'Regan, J. P.; Deng, H. X.; Rahmani, Z.; Krizus, A.; McKenna- Yasek, D.; Cayabyab, A.; Gaston, S.; Tanzi, R.; Halperin, J. J.; Herzfeldt, B.; Van den Berg, R.; Hung, W. Y.; Bird, T.; Deng, G.; Mulder, D. W.; Smith, C.; Laing, N. G.; Soriano, E.; Pericak-Vance, M. A.; Haines, J.; Rouleau, G. A.; Gusella, J.; Horvitz, H. R.; Brown, R. H., Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62; 1993.
55. Rothstein, J. D. Of mice and men: Reconciling preclinical ALS mouse studies and human clinical trials. Ann. Neurol. 53:423-426; 2003.
56. Satake, K.; Lou, J.; Lenke, L. G. Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine 29:1971-1979; 2004.
57. Shaw, P. J.; Ince, P. G. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J. Neurol. 244 Suppl 2:S3-S14; 1997.
58. Son, B. R.; Marquez-Curtis, L. A.; Kucia, M.; Wysoczynski, M.; Turner, A. R.; Ratajczak, J.; Ratajczak, M. Z.; Janowska-Wieczorek, A. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264; 2006.
59. Tohill, M.; Terenghi, G. Stem-cell plasticity and therapy for injuries of the peripheral nervous system. Biotech. Appl. Biochem. 40:17-24; 2004.
60. Vercelli, A.; Mereuta, O. M.; Garbossa, D.; Muraca, G.; Mareschi, K.; Rustichelli, D.; Ferrero, I.; Mazzini, L.; Madon, E.; Fagioli, F. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol. Disease 31:395-405; 2008.
61. Wang, L.; Li, Y.; Chen, J.; Gautam, S. C.; Zhang, Z.; Lu, M.; Chopp, M. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp. Hematol. 30:831-836; 2002.
62. Wang, L.; Li, Y.; Chen, X.; Chen, J.; Gautam, S. C.; Xu, Y.; Chopp, M. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7:113-117; 2002.
63. Warita, H.; Itoyama, Y.; Abe, K. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res. 819:120-131; 1999.
64. Weydt, P.; Hong, S. Y.; Kliot, M.; Moller, T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 14:1051-1054; 2003.
65. Wieczorek, G.; Steinhoff, C.; Schulz, R.; Scheller, M.; Vingron, M.; Ropers, H. H.; Nuber, U. A. Gene expression profile of mouse bone marrow stromal cells determined by cDNA microarray analysis. Cell Tissue Res. 311:227-237; 2003.
66. Willing, A. E.; Garbuzova-Davis, S.; Saporta, S.; Milliken, M.; Cahill, D. W.; Sanberg, P. R. hNT neurons delay onset of motor deficits in a model of amyotrophic lateral sclerosis. Brain Res. Bull. 56:525-530; 2001.
67. Woodbury, D.; Schwarz, E. J.; Prockop, D. J.; Black, I. B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61:364-370; 2000.
68. Xu, L.; Yan, J.; Chen, D.; Welsh, A. M.; Hazel, T.; Johe, K.; Hatfield, G.; Koliatsos, V. E. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 82:865-875; 2006.
69. Yan, J.; Xu, L.; Welsh, A. M.; Chen, D.; Hazel, T.; Johe, K.; Koliatsos, V. E. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 24:1976-1985; 2006.
70. Yoo, S. W.; Kim, S. S.; Lee, S. Y.; Lee, H. S.; Kim, H. S.; Lee, Y. D.; Suh-Kim, H. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp. Mol. Med. 40:387-397; 2008.
71. Zhang, C.; Zhou, C.; Teng, J. J.; Zhao, R. L.; Song, Y. Q. Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis. Cytotherapy 11:299-306; 2009.
72. Zhao, C. P.; Zhang, C.; Zhou, S. N.; Xie, Y. M.; Wang, Y. H.; Huang, H.; Shang, Y. C.; Li, W. Y.; Zhou, C.; Yu, M. J.; Feng, S. W. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice. Cytotherapy 9:414-426; 2007.
73. Zhao, L. R.; Duan, W. M.; Reyes, M.; Keene, C. D.; Verfaillie, C. M.; Low, W. C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174:11-20; 2002.
74. Zhong, Z.; Deane, R.; Ali, Z.; Parisi, M.; Shapovalov, Y.; O'Banion, M. K.; Stojanovic, K.; Sagare, A.; Boillee, S.; Cleveland, D. W.; Zlokovic, B. V. ALScausing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 11:420-422; 2008.